New pill for scarred lungs shows promise in early trial
Disease control
Completed
This study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal was to see if the drug is safe and tolerable over 12 weeks compared to a placebo. Resea…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC